UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 177

Sortiert nach

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma

Journal of thoracic oncology, 2016-10, Vol.11 (10), p.1690-1700

2016

Volltextzugriff (PDF)

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population

The lancet oncology, 2013-10, Vol.14 (11), p.1067-1076

2013

Volltextzugriff (PDF)

Breast Cancer Index Identifies Early-Stage Estrogen Receptor-Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence

Clinical cancer research, 2013-08, Vol.19 (15), p.4196-4205

2013

Volltextzugriff (PDF)

Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker

JNCI : Journal of the National Cancer Institute, 2013-07, Vol.105 (14), p.1036-1042

2013

Volltextzugriff (PDF)

Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine

Clinical cancer research, 2017-08, Vol.23 (16), p.4716-4723

2017

Volltextzugriff (PDF)

Gene expression profiling of the tumor microenvironment during breast cancer progression

Breast cancer research : BCR, 2009-01, Vol.11 (1), p.R7-R7, Article R7

2009

Volltextzugriff (PDF)

BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy

Cancer discovery, 2016-06, Vol.6 (6), p.594-600

2016

Volltextzugriff (PDF)

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer

PloS one, 2019-11, Vol.14 (11), p.e0224420

2019

Volltextzugriff (PDF)

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

Proceedings of the National Academy of Sciences - PNAS, 2007-12, Vol.104 (50), p.19936-19941

2007

Volltextzugriff (PDF)

Gene Expression Profiles of Human Breast Cancer Progression

Proceedings of the National Academy of Sciences - PNAS, 2003-05, Vol.100 (10), p.5974-5979

2003

Volltextzugriff (PDF)

Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling

Cancer research (Chicago, Ill.), 2023-01, Vol.83 (2), p.219-238

2023

Volltextzugriff (PDF)

The HOXB13:IL17BR Expression Index Is a Prognostic Factor in Early-Stage Breast Cancer

Journal of clinical oncology, 2006-10, Vol.24 (28), p.4611-4619

2006

Volltextzugriff (PDF)

Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by α1-blockers

European journal of pharmacology, 2020-04, Vol.873, p.172985, Article 172985

2020

Volltextzugriff (PDF)

Longitudinal monitoring of ctDNA EGFR mutation burden from urine correlates with patient response to EGFR TKIs: A case series

Lung cancer (Amsterdam, Netherlands), 2017-06, Vol.108, p.22-28

2017

Volltextzugriff (PDF)

Molecular Profiling in Unknown Primary Cancer: Accuracy of Tissue of Origin Prediction

The oncologist (Dayton, Ohio), 2010-05, Vol.15 (5), p.500-506

2010

Volltextzugriff (PDF)

Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral Population

Cancer epidemiology, biomarkers & prevention, 2017-07, Vol.26 (7), p.1053-1059

2017

Volltextzugriff (PDF)

A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer

Clinical cancer research, 2008-05, Vol.14 (9), p.2601-2608

2008

Volltextzugriff (PDF)

Performance and Clinical Evaluation of the 92-Gene Real-Time PCR Assay for Tumor Classification

The Journal of molecular diagnostics : JMD, 2011-09, Vol.13 (5), p.493-503

2011

Volltextzugriff (PDF)

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

Cancer cell, 2004-06, Vol.5 (6), p.607-616

2004

Volltextzugriff (PDF)

Development and validation of a 32-gene prognostic index for prostate cancer progression

Proceedings of the National Academy of Sciences - PNAS, 2013-04, Vol.110 (15), p.6121-6126

2013

Volltextzugriff (PDF)

Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer

Breast cancer research : BCR, 2011-10, Vol.13 (5), p.R98-R98, Article R98

2011

Volltextzugriff (PDF)

Analysis of the effect of various decalcification agents on the quantity and quality of nucleic acid (DNA and RNA) recovered from bone biopsies

Annals of diagnostic pathology, 2013-08, Vol.17 (4), p.322-326

2013

Volltextzugriff (PDF)

Urine test for EGFR analysis in patients with non-small cell lung cancer

Journal of thoracic disease, 2017-10, Vol.9 (Suppl 13), p.S1323-S1331

2017

Volltextzugriff (PDF)

Multisite Validation Study to Determine Performance Characteristics of a 92-Gene Molecular Cancer Classifier

Clinical cancer research, 2012-07, Vol.18 (14), p.3952-3960

2012

Volltextzugriff (PDF)

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(173)

Publikationsform

Sprache

Englisch
(177)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(65)
Humans
(62)
Female
(37)
Oncology
(37)
Middle Aged
(26)
Biological And Medical Sciences
(24)
Animals
(23)
Aged
(21)
Adult
(20)
Gene Expression Profiling
(18)
Male
(18)
Tumors
(17)
Prognosis
(16)
Breast Cancer
(15)
Breast Neoplasms - Genetics
(15)
Fundamental And Applied Biological Sciences. Psychology
(14)
Molecular Sequence Data
(14)
Rats
(14)
Gene Expression
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population

Breast Cancer Index Identifies Early-Stage Estrogen Receptor-Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence

Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker

Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine

Gene expression profiling of the tumor microenvironment during breast cancer progression

BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

Gene Expression Profiles of Human Breast Cancer Progression

Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling

The HOXB13:IL17BR Expression Index Is a Prognostic Factor in Early-Stage Breast Cancer

Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by α1-blockers

Longitudinal monitoring of ctDNA EGFR mutation burden from urine correlates with patient response to EGFR TKIs: A case series

Molecular Profiling in Unknown Primary Cancer: Accuracy of Tissue of Origin Prediction

Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral Population

A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer

Performance and Clinical Evaluation of the 92-Gene Real-Time PCR Assay for Tumor Classification

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers

Development and validation of a 32-gene prognostic index for prostate cancer progression

Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer

Analysis of the effect of various decalcification agents on the quantity and quality of nucleic acid (DNA and RNA) recovered from bone biopsies

Urine test for EGFR analysis in patients with non-small cell lung cancer

Multisite Validation Study to Determine Performance Characteristics of a 92-Gene Molecular Cancer Classifier

Suchergebnisse filtern